Medpace Holdings (MEDP) Gross Margin (2015 - 2026)

Medpace Holdings has reported Gross Margin for 12 years, with the latest figure at 27.78% in Q1 2026.

• For the quarter ending Q1 2026, Gross Margin fell 415.0% year-over-year to 27.78%; the trailing twelve-month figure through Mar 2026 stood at 29.07% (down 244.0% YoY), and the FY2025 full-year result was 30.06%, down 106.0% from the prior year.
• Gross Margin for Q1 2026 stood at 27.78%, down from 28.98% in the prior quarter.
• The five-year high for Gross Margin was 33.23% in Q4 2024, with the low at 26.97% in Q2 2023.
• Historically, Gross Margin has averaged 29.57% across 5 years, with a median of 29.82% in 2022.
• Annual changes were most pronounced in 2024 — Gross Margin soared 578 bps — and 2025, when it tumbled 425 bps.
• Medpace Holdings' Gross Margin stood at 29.37% in 2022, then decreased by 7 bps to 27.45% in 2023, then gained by 21 bps to 33.23% in 2024, then declined by 13 bps to 28.98% in 2025, then retreated by 4 bps to 27.78% in 2026.
• The last three Gross Margin figures came in at 27.78% (Q1 2026), 28.98% (Q4 2025), and 29.84% (Q3 2025), per Business Quant data.